Oncogenic N-Ras Mitigates Oxidative Stress–Induced Apoptosis of Hematopoietic Stem Cells
- 13 January 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (5), 1240-1251
- https://doi.org/10.1158/0008-5472.can-20-0118
Abstract
Leukemic relapse is believed to be driven by transformed hematopoietic stem cells that harbor oncogenic mutations or have lost tumor suppressor function. Recent comprehensive sequencing studies have shown that mutations predicted to activate Ras signaling are highly prevalent in hematologic malignancies and, notably, in refractory and relapsed cases. To better understand what drives this clinical phenomenon, we expressed oncogenic NrasG12D within the hematopoietic system in mice and interrogated its effects on hematopoietic stem cell (HSC) survival. N-RasG12D conferred a survival benefit to HSC and progenitors following metabolic and genotoxic stress. This effect was limited to HSC and early progenitors and was independent of autophagy and cell proliferation. N-RasG12D-mediated HSC survival was not affected by inhibition of the canonical Ras effectors such as MEK and PI3K. However, inhibition of the non-canonical Ras effector pathway protein kinase C (PKC) ameliorated the protective effects of N-RasG12D. Mechanistically, N-RasG12D lowered levels of reactive oxygen species (ROS), which correlated with reduced mitochondrial membrane potential and ATP levels. Inhibition of PKC restored the levels of ROS to that of control HSC and abrogated the protective effects granted by N-RasG12D. Thus, N-RasG12D activation within HSC promote cell survival through the mitigation of ROS, and targeting this mechanism may represent a viable strategy to induce apoptosis during malignant transformation of HSC.Funding Information
- NIH (P30CA046592)
- NIH NHLBI (5-T32-HL007622)
- NIH (5-K12-HD028820-25)
- NIH NHLBI (R01HL132392, 1R01HL150707)
- American Cancer Society (125080-RSG-13-253-01-LIB)
This publication has 64 references indexed in Scilit:
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stressProceedings of the National Academy of Sciences of the United States of America, 2011
- Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung TumorsCancer Research, 2011
- The autophagy protein Atg7 is essential for hematopoietic stem cell maintenanceThe Journal of Experimental Medicine, 2011
- Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locusBlood, 2011
- Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and MutagenesisCell Stem Cell, 2010
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem CellsScience Translational Medicine, 2010
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cellsNature Biotechnology, 2008
- Structural Basis of Protein Kinase C Isoform FunctionPhysiological Reviews, 2008